City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
   
The following is a list of available studies directed by  Anna Pawlowska, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
 
Click here to generate a printer-friendly view  
 08132
   P.I.: Anna Pawlowska, MD (Cooperative Group)
Title: BMT CTN 0601: Unrelated Donor Hematopoietic Cell Transplantation for Children with Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen
 
Click here for  Full Eligibility Criteria
 07081
   P.I.: Anna Pawlowska, MD (Institutional)
Title: Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients with Severe Aplastic Anemia
 
Click here for  Full Eligibility Criteria
 03112
   P.I.: Anna Pawlowska, MD (Institutional)
Title: Pilot Study of High-Dose Chemotherapy with Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors
 
Click here for  Full Eligibility Criteria
 

  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.